Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer: an update.

R P Huben, G P Murphy

    CA: a Cancer Journal for Clinicians
    |September 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Recent advances have improved understanding and treatment of prostate cancer. Further research with larger patient groups is needed to establish optimal management strategies for this impactful disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli.

    Journal of general microbiology·1992
    Same author

    Revision in American Cancer Society recommendations for the early detection of colorectal cancer.

    CA: a cancer journal for clinicians·1992
    Same author

    The association of benign prostatic hyperplasia and cancer of the prostate.

    Cancer·1992
    Same author

    Relapsing disease.

    Cancer·1992
    Same author

    The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project.

    Cancer·1992
    Same author

    Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.

    Cancer·1992
    Same journal

    Extranodal natural killer/T-cell lymphoma: From fatal to curable.

    CA: a cancer journal for clinicians·2026
    Same journal

    Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

    CA: a cancer journal for clinicians·2026
    Same journal

    Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

    CA: a cancer journal for clinicians·2026
    Same journal

    Correction to "Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastases".

    CA: a cancer journal for clinicians·2026
    See all related articles

    Area of Science:

    • Oncology
    • Urology

    Background:

    • Prostate cancer diagnosis and treatment present numerous challenges and unanswered questions.
    • Significant progress has been made in understanding the complexities of prostate cancer in recent years.

    Purpose of the Study:

    • To review recent advancements in prostate cancer research.
    • To highlight the need for unified and rational approaches to treatment.
    • To identify areas requiring further investigation.

    Main Methods:

    • This is a review article, synthesizing existing research and clinical observations.
    • It discusses the current state of knowledge regarding prostate cancer nature and treatment.

    Main Results:

    • Major advances have been achieved in understanding prostate cancer.

    Related Experiment Videos

  • Emerging unified treatment approaches may reduce current management controversies.

    • Conclusions:

    • Continued research with larger, well-defined patient cohorts is essential.
    • Determining preferred treatment strategies requires robust evidence from carefully designed studies.
    • Addressing prostate cancer's significant health impact necessitates further scientific inquiry.